LataMed AI Corp. Stock

LMED

US21116R4048

Office Equipment

Market Closed - OTC Markets 03:58:17 12/09/2026 HKT			5-day change	1st Jan Change
0.3800 ^USD	-10.50%		-11.63%	+192.26%

08-19	Latamed Ai Corp. Nears Completion of Mobile Healthcare Application	CI
08-12	LataMed AI VE Enters Strategic Collaboration With Caracas FC to Explore AI-Powered Athletic Performance and Operational Analytics	CI

LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.

Employees

Sector

Office Equipment

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	US$0.3800	-10.50%	159,385
10/09/26	US$0.4246	+11.68%	270,302
09/09/26	US$0.3802	-5.09%	37,216
08/09/26	US$0.4006	-6.84%	170,323

Delayed Quote OTC Markets

More quotes

Market Cap	68.66M 59.15M 56.01M 50.77M 95.24M 6.56B 95.73M 665M 256M 3.34B 258M 252M 10.54B	P/E 2024	-3.63x	P/E 2025	-102x
Enterprise Value	69.05M 59.49M 56.33M 51.06M 95.79M 6.6B 96.28M 669M 257M 3.36B 259M 254M 10.61B	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	19.29%	Yield 2024 *	-	Yield 2025	-

08-19	Latamed Ai Corp. Nears Completion of Mobile Healthcare Application	CI
08-12	LataMed AI VE Enters Strategic Collaboration With Caracas FC to Explore AI-Powered Athletic Performance and Operational Analytics	CI
08-12	LataMed AI Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-03	LataMed AI Corp. And DROGUERIAS LALA C.A. Enter Agreement To Develop AI And Automation Tools For Pharmaceutical And Laboratory Workflows	CI
07-31	LataMed AI Corp. And Venezuelan Institute For Scientific Research Enter Agreement To Develop Digital Platform Supporting Access To IVIC Laboratory Services	CI
07-28	LataMed AI Corp. Announces Through its Venezuelan Operating Subsidiary Enters Agreements with Colegio Claret and Colegio Roraima to Develop School-Based Digital Healthcare Initiatives	CI
07-23	LataMed AI Corp. through its subsidiary LATAMEDAI VE, and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations	CI
07-20	LataMed AI Corp Advances Industrial Telemedicine Initiative For Remote And Offshore Operations In Venezuela	CI
07-06	LataMed AI Corp. Begins Planned Expansion into Colombia Through Initial Due Diligence and Strategic Planning	CI
07-01	Latamed Ai Ve Executes Strategic Commercial Alliance with Cantv to Expand Digital Healthcare Services Across Venezuela	CI
06-30	Latamed Ai Corp. and Vértice Seguros C.A. Execute Strategic Commercial Alliance to Expand Digital Healthcare and Insurance Ecosystem	CI
06-24	LataMed AI Corp. And Focus Fitness C.A. Execute Strategic Commercial And Services Agreement	CI
06-11	LataMed AI Corp Initiates Strategic Process to Evaluate Installment-Based Healthcare Payment Integration with Cashea Platform	CI

07-15	LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split	EQ
07-13	LataMed AI Begins Evaluating Global Healthcare Expansion Opportunities Through Planned Attendance at World Health Expo 2027	EQ
07-09	LataMed AI Chief Executive Officer Dr. Kevin Rodan to Be Recognized by Ministry of Health for Healthcare Innovation	EQ
07-08	LataMed AI Provides Shareholder Update Regarding Upcoming 5-for-1 Forward Stock Split and Mandatory Share Exchange Process	EQ
07-06	LataMed AI Begins Planned Expansion Into Colombia Through Initial Due Diligence and Strategic Planning	EQ

1 day	-10.50%
1 week	-11.63%
Current month	-13.68%
1 month	-37.70%
3 months	-22.13%
6 months	+113.48%
Current year	+192.26%

1 week	0.36	0.49
1 month	0.34	0.58
Current year	0.1	1.38
1 year	0.1	1.38
3 years	0.05	135
5 years	0.05	135
10 years	0.05	135

LataMed AI Corp. Stock

Stocks

LMED

US21116R4048

Office Equipment

Valuation: LataMed AI Corp.

Chart: LataMed AI Corp.

Latest news: LataMed AI Corp.

Press Releases: LataMed AI Corp.

Quotes and Performance

Price Extremes

Managers and Directors: LataMed AI Corp.

Commercial Document Management

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Kevin Levy CEO	Chief Executive Officer	31	17/02/2026
Carlos Peña DFI	Director of Finance/CFO	38	31/03/2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LATAMED AI CORP.	-10.50%	-11.63%	+153.33%	-96.54%	68.66M
EASTMAN KODAK COMPANY	+4.26%	+0.22%	+54.65%	+126.52%	912M
XEROX HOLDINGS CORPORATION	+8.20%	+3.31%	-6.79%	-78.06%	450M
RISO KAGAKU CORPORATION	+3.07%	-3.16%	-14.52%	-13.02%	411M
JOLIMARK HOLDINGS LIMITED	-7.76%	-14.86%	+2,525.00%	+2,118.31%	374M
SINDOH CO.,LTD.	-0.38%	-2.38%	-13.03%	+20.90%	241M
TECO IMAGE SYSTEMS CO., LTD.	-0.60%	-0.30%	-41.45%	-3.49%	59.06M
Average	-0.53%	+7.22%	+379.60%	+296.37%	359.29M
Weighted average by Cap.	+2.02%	+9.30%	+393.40%	+343.81%

	2024	2025
Net sales	-	-
Net income	-3.26M -2.81M -2.66M -2.41M -4.52M -312M -4.55M -31.6M -12.15M -159M -12.25M -11.98M -501M	-207K -179K -169K -153K -288K -19.82M -289K -2.01M -773K -10.08M -779K -762K -31.87M
Net Debt	339K 292K 277K 251K 471K 32.42M 473K 3.29M 1.26M 16.49M 1.27M 1.25M 52.12M	395K 340K 322K 292K 548K 37.73M 551K 3.83M 1.47M 19.2M 1.48M 1.45M 60.66M